Lamivudine-resistant HBV mutants in patients with anti-Hbe positive chronic hepatitis B treated with long-term lamivudine monotherapy
2002-01-01 Santantonio, TERESA ANTONIA; Sinisi, E.; Insalata, M.; Palumbo, E.; Guastadisegni, A.; Pastore, G.
Interferon alone versus interferon plus ribavirin in the treatment of patients with acute hepatitis C
2002-01-01 Santantonio, TERESA ANTONIA; Sinisi, E.; Guastadisegni, A.; Palumbo, E.; Pastore, G.
Long term lamivudine in patients with anti-Hbe/HBV-DNA positive liver disease
2002-01-01 Di Marco, V.; Lampertico, P.; Marzano, A.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P.; Rizzetto, M.; Craxì, A.
Human immune deficiency virus(HIV) co-infection impairs responsiveness to interferon (IFN) and ribavirin (RBV) combination in patients with chronic hepatitis C: Preliminary results of a comparative study
2002-01-01 Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Cavaliere, R.; Castelli, F.; Zaltron, S.; Roldan, E. q.; Suter, F.; Pastore, G.; Carosi, G.
Preliminary results of a randomized multicenter controlled trial comparing interferon (IFN) thrice weekly in combination with ribavirin (RBV) with interferon daily in combination with ribavirin and amantadine (AMA) in the treatment of chronic hepatitis C in human immune deficiency virus (HIV) co-infected patients
2002-01-01 Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Cavaliere, R.; Roldan, E. q.; Castelli, F.; Suter, F.; Pastore, G.; Carosi, G.
High interferon (IFN) daily doses in combination with ribavirin (RBV) are cost effective in the treatment of hepatitis C in HIV coinfected subjects without sustained response to interferon monotherapy
2002-01-01 Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Scalise, G.; Ghinelli, F.; Chiodo, R.; Pastore, G.; Castelli, F.; Carosi, G.
Clinical events during long term lamivudine treatment in anti-HBe/HBV DNA positive chronic liver diseases
2003-01-01 Di Marco, V.; Marzano, A.; Lampertico, P.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P. l.; Rizzetto, M.; Craxì, A.
Genotypic analysis of YMDD locus of HBV in patients responding to lamivudine monotherapy.
2003-01-01 Lampertico, P.; Seletti, C.; Vigano, M.; Marzano, A.; Andreone, P.; Santantonio, TERESA ANTONIA; Di Marco, V.; Iavarone, M.; Lunghi, G.; Del Ninno, E.; Colombo, M.
The course of anti-HBe/HBV-DNA positive chronic liver disease during long term lamivudine treatment
2003-01-01 Di Marco, V.; Marzano, A.; Lampertico, P.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P. l.; Rizzetto, M.; Craxìa,
Successful treatment of acute hepatitis C with alpha-2b Peg-Interferon monotherapy: an interim analysis
2003-01-01 Santantonio, TERESA ANTONIA; Sinisi, E.; Signorile, F.; Guastadisegni, A.; Casalino, C.; Mazzola, M.; Francavilla, R.; Pastore, G.
Efficacy of peg-interferon alpha-2b (pegintron) monotherapy in acute hepatitis C: a preliminary analysis
2004-01-01 Santantonio, TERESA ANTONIA; Sinisi, E.; Signorile, F.; Guastadisegni, A.; Casalino, C.; Mazzola, M.; Francavilla, R.; Pastore, G.
.Dynamics of HBV-DNA and infected hepatocytes described by a new bio-mathematical model in chronic hepatitis B patients treated with lamivudine and in patients with YMDD mutants treated with adefovir
2004-01-01 Bizzarri, R.; Colombatto, P.; Civitano, L.; Flichman, D.; Ciccorossi, P.; Sacco, R.; Olivieri, F.; Coco, B.; Maina, A.; Bonino, F.; Santantonio, TERESA ANTONIA; Brunetto, M.
IFN impact on liver disease progression in HBeAg negative chronic hepatitis B (CHB): a long-term Italian multicenter AISF study
2005-01-01 Oliveri, F.; Puoti, M.; Santantonio, TERESA ANTONIA; Lampertico, P.; Colloredo, G.; Niro, G.; Fattovich, G.; Morisco, F.; Marrone, A.; Costa, P.; Felder, M.; Cacciatore, P.; Smedile, A.; Brunetto, M. r.
.Long-term lamivudine treatment in patients with HBeAg negative chronic hepatitis B: how long?
2005-01-01 Signorile, F.; Fasano, Massimo; Chidichimo, L.; Guastadisegni, A.; Pastore, G.; Santantonio, TERESA ANTONIA
A multicenter Italian study of rescue Adefovir Dipivoxil therapy in lamivudine resistant patients: a 2-year analysis of 604 patients
2005-01-01 Lampertico, P.; Marzano, A.; Levrero, M.; Santantonio, TERESA ANTONIA; Andreone, P.; Brunetto, M.; Di Marco, V.; Fagiuoli, S.; Mazzella, G.; Raimondo, G.
Current epidemiological trends and outcome in a large cohort of acute hepatitis C patients
2005-01-01 Santantonio, TERESA ANTONIA; Ferrari, C.; Fabris, P.; Cariti, G.; Massari, M.; Babudieri, S.; Toti, M.; Francavilla, R.; Ancarani, F.; Antonucci, G.; Scotto, G.; Di Marco, V.; Stroffolini, T.
Long-term outcome of patients with HCV-related, Child’s class A cirrhosis treated with interferon-alpha (IFN): the impact of sustained virologic response (SVR) on hepatocellular carcinoma (HCC) occurrence and mortality
2005-01-01 Bruno, S.; Stroffolini, T.; Bollani, S.; Benvegnù, L.; Gaeta, G. b.; Persico, M.; Mazzella, G.; Ascione, A.; Mangia, A.; Santantonio, TERESA ANTONIA; Andreone, P.; Almasio, P. l.
Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic epatiti B
2006-01-01 Lampertico, .; P, Marzano A.; Levrero, M.; Santantonio, TERESA ANTONIA; Di Marco, V.; Brunetto, M.; Andreone, P.; Sagnelli, E.; Fagiuoli, S.; Mazzella, G.; Raimondo, G.; Gaeta, G. b.; Ascione, A.
A multicenter Italian study of rescue Adefovir Dipivoxil therapy in lamivudine resistant patients: a 2-year analysis of 650 patients
2006-01-01 Lampertico, P.; Marzano, A.; Levrero, M.; Santantonio, TERESA ANTONIA; Andreone, P.; Brunetto, M.; Di Marco, V.; Fagiuoli, S.; Mazzella, G.; Raimondo, G.
Real-time PCR quantification of total intracellular HBV DNA and cccDNA in HBsAg-positive patients with and without HDV co-infection and in patients with occult HBV infection
2007-01-01 Pollicino, T.; Raffa, G.; Santantonio, TERESA ANTONIA; Squadrito, G.; Milella, M.; Colucci, G.; Calvi, C.; Cacciola, I.; Levrero, M.; Raimondo, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Lamivudine-resistant HBV mutants in patients with anti-Hbe positive chronic hepatitis B treated with long-term lamivudine monotherapy | 1-gen-2002 | Santantonio, TERESA ANTONIA; Sinisi, E.; Insalata, M.; Palumbo, E.; Guastadisegni, A.; Pastore, G. | |
| Interferon alone versus interferon plus ribavirin in the treatment of patients with acute hepatitis C | 1-gen-2002 | Santantonio, TERESA ANTONIA; Sinisi, E.; Guastadisegni, A.; Palumbo, E.; Pastore, G. | |
| Long term lamivudine in patients with anti-Hbe/HBV-DNA positive liver disease | 1-gen-2002 | Di Marco, V.; Lampertico, P.; Marzano, A.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P.; Rizzetto, M.; Craxì, A. | |
| Human immune deficiency virus(HIV) co-infection impairs responsiveness to interferon (IFN) and ribavirin (RBV) combination in patients with chronic hepatitis C: Preliminary results of a comparative study | 1-gen-2002 | Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Cavaliere, R.; Castelli, F.; Zaltron, S.; Roldan, E. q.; Suter, F.; Pastore, G.; Carosi, G. | |
| Preliminary results of a randomized multicenter controlled trial comparing interferon (IFN) thrice weekly in combination with ribavirin (RBV) with interferon daily in combination with ribavirin and amantadine (AMA) in the treatment of chronic hepatitis C in human immune deficiency virus (HIV) co-infected patients | 1-gen-2002 | Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Cavaliere, R.; Roldan, E. q.; Castelli, F.; Suter, F.; Pastore, G.; Carosi, G. | |
| High interferon (IFN) daily doses in combination with ribavirin (RBV) are cost effective in the treatment of hepatitis C in HIV coinfected subjects without sustained response to interferon monotherapy | 1-gen-2002 | Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Scalise, G.; Ghinelli, F.; Chiodo, R.; Pastore, G.; Castelli, F.; Carosi, G. | |
| Clinical events during long term lamivudine treatment in anti-HBe/HBV DNA positive chronic liver diseases | 1-gen-2003 | Di Marco, V.; Marzano, A.; Lampertico, P.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P. l.; Rizzetto, M.; Craxì, A. | |
| Genotypic analysis of YMDD locus of HBV in patients responding to lamivudine monotherapy. | 1-gen-2003 | Lampertico, P.; Seletti, C.; Vigano, M.; Marzano, A.; Andreone, P.; Santantonio, TERESA ANTONIA; Di Marco, V.; Iavarone, M.; Lunghi, G.; Del Ninno, E.; Colombo, M. | |
| The course of anti-HBe/HBV-DNA positive chronic liver disease during long term lamivudine treatment | 1-gen-2003 | Di Marco, V.; Marzano, A.; Lampertico, P.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P. l.; Rizzetto, M.; Craxìa, | |
| Successful treatment of acute hepatitis C with alpha-2b Peg-Interferon monotherapy: an interim analysis | 1-gen-2003 | Santantonio, TERESA ANTONIA; Sinisi, E.; Signorile, F.; Guastadisegni, A.; Casalino, C.; Mazzola, M.; Francavilla, R.; Pastore, G. | |
| Efficacy of peg-interferon alpha-2b (pegintron) monotherapy in acute hepatitis C: a preliminary analysis | 1-gen-2004 | Santantonio, TERESA ANTONIA; Sinisi, E.; Signorile, F.; Guastadisegni, A.; Casalino, C.; Mazzola, M.; Francavilla, R.; Pastore, G. | |
| .Dynamics of HBV-DNA and infected hepatocytes described by a new bio-mathematical model in chronic hepatitis B patients treated with lamivudine and in patients with YMDD mutants treated with adefovir | 1-gen-2004 | Bizzarri, R.; Colombatto, P.; Civitano, L.; Flichman, D.; Ciccorossi, P.; Sacco, R.; Olivieri, F.; Coco, B.; Maina, A.; Bonino, F.; Santantonio, TERESA ANTONIA; Brunetto, M. | |
| IFN impact on liver disease progression in HBeAg negative chronic hepatitis B (CHB): a long-term Italian multicenter AISF study | 1-gen-2005 | Oliveri, F.; Puoti, M.; Santantonio, TERESA ANTONIA; Lampertico, P.; Colloredo, G.; Niro, G.; Fattovich, G.; Morisco, F.; Marrone, A.; Costa, P.; Felder, M.; Cacciatore, P.; Smedile, A.; Brunetto, M. r. | |
| .Long-term lamivudine treatment in patients with HBeAg negative chronic hepatitis B: how long? | 1-gen-2005 | Signorile, F.; Fasano, Massimo; Chidichimo, L.; Guastadisegni, A.; Pastore, G.; Santantonio, TERESA ANTONIA | |
| A multicenter Italian study of rescue Adefovir Dipivoxil therapy in lamivudine resistant patients: a 2-year analysis of 604 patients | 1-gen-2005 | Lampertico, P.; Marzano, A.; Levrero, M.; Santantonio, TERESA ANTONIA; Andreone, P.; Brunetto, M.; Di Marco, V.; Fagiuoli, S.; Mazzella, G.; Raimondo, G. | |
| Current epidemiological trends and outcome in a large cohort of acute hepatitis C patients | 1-gen-2005 | Santantonio, TERESA ANTONIA; Ferrari, C.; Fabris, P.; Cariti, G.; Massari, M.; Babudieri, S.; Toti, M.; Francavilla, R.; Ancarani, F.; Antonucci, G.; Scotto, G.; Di Marco, V.; Stroffolini, T. | |
| Long-term outcome of patients with HCV-related, Child’s class A cirrhosis treated with interferon-alpha (IFN): the impact of sustained virologic response (SVR) on hepatocellular carcinoma (HCC) occurrence and mortality | 1-gen-2005 | Bruno, S.; Stroffolini, T.; Bollani, S.; Benvegnù, L.; Gaeta, G. b.; Persico, M.; Mazzella, G.; Ascione, A.; Mangia, A.; Santantonio, TERESA ANTONIA; Andreone, P.; Almasio, P. l. | |
| Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic epatiti B | 1-gen-2006 | Lampertico, .; P, Marzano A.; Levrero, M.; Santantonio, TERESA ANTONIA; Di Marco, V.; Brunetto, M.; Andreone, P.; Sagnelli, E.; Fagiuoli, S.; Mazzella, G.; Raimondo, G.; Gaeta, G. b.; Ascione, A. | |
| A multicenter Italian study of rescue Adefovir Dipivoxil therapy in lamivudine resistant patients: a 2-year analysis of 650 patients | 1-gen-2006 | Lampertico, P.; Marzano, A.; Levrero, M.; Santantonio, TERESA ANTONIA; Andreone, P.; Brunetto, M.; Di Marco, V.; Fagiuoli, S.; Mazzella, G.; Raimondo, G. | |
| Real-time PCR quantification of total intracellular HBV DNA and cccDNA in HBsAg-positive patients with and without HDV co-infection and in patients with occult HBV infection | 1-gen-2007 | Pollicino, T.; Raffa, G.; Santantonio, TERESA ANTONIA; Squadrito, G.; Milella, M.; Colucci, G.; Calvi, C.; Cacciola, I.; Levrero, M.; Raimondo, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1346
Data di pubblicazione
- 2020 - 202643
- 2010 - 2019591
- 2000 - 2009493
- 1990 - 1999180
- 1980 - 198935
- 1974 - 19794
Editore
- Edizioni Ets:Piazza Carrara 16-19...3
- New York ; : Taylor & Francis, 20...2
- Editrice Kurtis Srl:via Luigi Zoj...1
Rivista
- DIGESTIVE AND LIVER DISEASE78
- THE JOURNAL OF THE AMERICAN ASSOC...72
- EUROPEAN RESPIRATORY JOURNAL71
- JOURNAL OF HEPATOLOGY69
- GIORNALE ITALIANO DI PSICOPATOLOGIA54
- HEPATOLOGY50
- ARCHIVES OF DISEASE IN CHILDHOOD26
- MEDITERRANEAN JOURNAL OF CLINICAL...26
- JOURNAL OF PEDIATRIC GASTROENTERO...23
- DIGESTIVE AND LIVER DISEASE. SUPP...20
Keyword
- children15
- obesity5
- exercise4
- Physical education4
- grapevine3
- kidney3
- Metabolic syndrome3
- physical activity3
- physical education3
- primary school3
Lingua
- eng734
- ita155
- fre1
Accesso al fulltext
- no fulltext1346